Who Paid My Doc
An Open-Label, Multi-Center, Phase I Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of 2-Week Treatment with Inhaled AZD7594 in Adolescents 12 to 17 years with Asthma (AMBER)
Research payments
$937,699
Through program year 2021, $937,699 in research payments was reported against An Open-Label, Multi-Center, Phase I Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of 2-Week Treatment with Inhaled AZD7594 in Adolescents 12 to 17 years with Asthma (AMBER), across 38 payments, paid by AstraZeneca AB.
- Paid by
- AstraZeneca AB
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $126,497 | 10 |
| 2020 | Research | $792,125 | 24 |
| 2019 | Research | $19,077 | 4 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Fuentes Boerne, TX Named on 4 payments
- Robert Florea Columbus, OH Named on 4 payments
- Idalia Acosta Miami Lakes, FL Named on 4 payments
- John Ervin Kansas City, MO Named on 4 payments
- Lawrence Sher Rolling Hills Estates, CA Named on 4 payments
- Barbara Baxter Dallas, TX Named on 2 payments
- Andrew Smith Murray, UT Named on 2 payments
- Flory Kreutter Denver, CO Named on 2 payments
- Louise Thurman Oklahoma City, OK Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.